The DOI matches its Crossref record; 122 of the 128 references it cites were found in a registry or an index; 66 of the 129 sources its claims cite were checked for support.
Gestational Diabetes Mellitus—Recent Literature Review
Open accessAbstract
GDM is currently the most common medical complication in pregnancy and affects approximately 15% of pregnancies worldwide.
Overview
CoChat Summary
TL;DR
This narrative review summarizes recent literature on gestational diabetes mellitus (GDM), covering epidemiology, pathogenesis, diagnosis, and treatment. It reports that GDM is a common pregnancy complication with rising prevalence and highlights ongoing controversies in diagnostic criteria and treatment, especially regarding metformin and early screening.
Key findings
- GDM is described as the most common medical complication of pregnancy; the abstract reports it affects approximately 15% of pregnancies worldwide and accounts for approximately 18 million births annually, while the introduction cites IDF estimates of approximately 14.0% (95% CI 13.97–14.04%) of pregnancies worldwide, representing approximately 20 million births annually.
- Risk factors include age (GDM diagnosed in 6.7% of pregnancies overall but 8.5% in women over 30; highest risk at ages 35–39, OR 10.85 [7.72–15.25] vs. 2.59 [1.84–3.67]), previous GDM (more than sixfold recurrence risk), BMI ≥30 kg/m² (GDM frequency 12.3%), first-line relatives with GDM history (11.6%), combination of these two factors (up to 61%), PCOS (more than twice the percentage of pregnancies with GDM), IVF (50% increase), and summer season.
- Diagnosis uses IADPSG/WHO criteria (fasting plasma glucose ≥5.1 mmol/L, 1 h ≥10 mmol/L, 2 h ≥8.5 mmol/L during a 75 g OGTT); the HAPO study of 23,316 women showed a linear relationship between elevated glycemia and maternal/neonatal complications, IADPSG criteria produced a threefold increase in GDM diagnoses, and in a trial of 23,792 pregnant women one-step screening doubled GDM diagnosis without affecting LGA, adverse perinatal outcomes, primary Caesarean section, gestational hypertension, or pre-eclampsia.
- Treatment is primarily diet and increased exercise, with insulin, glibenclamide, and metformin used to intensify treatment; the MiG trial of 751 women found metformin alone or with supplemental insulin was not associated with increased perinatal complications, exercise reduced GDM risk by 38% (RR 0.62, 95% CI 0.41–0.94), 24%, and 42% (RR 0.58, 95% CI 0.37–0.90, p = 0.01) in different analyses, and ADA/ACOG still recommend insulin as primary medical treatment when lifestyle goals are not achieved.
Methods
- Narrative literature review analyzing currently available literature on the epidemiology, pathogenesis, diagnosis, and treatment of GDM, based on reviews, original articles, and meta-analyses published in English in the last 10 years.
- Literature search conducted from 1 January 2021 to 31 March 2022 using Web of Science, PubMed, EMBASE, Cochrane, Open Grey, and Grey Literature Report, with MeSH terms including “gestational diabetes”, “pregnancy induced diabetes”, “hyperglycemia”, “glucose intolerance”, “insulin resistance”, “prevalence”, “incidence”, “GDM treatment”, and “behavioral treatment”, used alone or in combination.
- Analysis was a narrative synthesis; no formal systematic review protocol, meta-analysis, or quality appraisal is described.
Limitations
- The paper states that due to the lack of randomized clinical trials, it is extremely difficult to propose an unambiguous and uniform management model; treatment is based on consensus and expert opinion; Cochrane analyses show a lack of unambiguous data on the correlation between intensity of glycemic control and obstetric outcomes; many doubts regarding diagnostic criteria and treatment remain; and screening/treatment for GDM early in pregnancy are very controversial due to lack of data from large randomized controlled trials.
- Evident from the text: this is a narrative review without described systematic quality assessment or PRISMA-style reporting, the search was restricted to English-language publications from the last 10 years, and prevalence figures differ between the abstract (approximately 15%, 18 million births annually) and the introduction (approximately 14.0%, 20 million births annually).
- Evident from the provided text: several subsection headings appear without accompanying content (e.g., 4.4.1 Insulin Resistance and 4.6.1–4.6.3 headings), limiting assessment of those specific details.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
51 Valid · 2 Not valid · 35 Not checked · 8 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The current criteria for the diagnosis of GDM introduced by The International Association of Diabetes and Pregnancy Study Groups (IADPSG), which were based on the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) results, found a threefold increase in GDM diagnoses, which suggests an earlier underestimation.”
§ Gestational Diabetes Mellitus—Recent Literature Review > 4. Results and Discussion > 4.3. Diagnosing GDM
What the sources say
- Partly supportedcites [27] Werner, 2012, Screening for gestational diabetes mellitus: Are the criteria proposed by the International Association of the Diabetes and Pregnancy Study Groups cost-effective?, Diabetes Care sourceExperimental — accuracy not yet measured
The introduction says the IADPSG criteria incorporated HAPO data, and the Conclusions describe a tripling of GDM diagnoses in the U.S. But the Results identify this as a model prediction, not an observed increase: diagnoses would rise from 5,020 to 17,800 per 100,000 women screened. The claim’s wording that the criteria “found” an increase overstates that evidence. Page numbers are unavailable in our copy. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [28] Williams, 1999, Effect of selective screening for gestational diabetes, Diabetes Care source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The greatest hopes are connected with afamine, adiponectin and 1,5-anhydroglucitol [34,35].”
§ Gestational Diabetes Mellitus—Recent Literature Review > 4. Results and Discussion > 4.3. Diagnosing GDM
What the sources say
- Partly supportedcites [34] Hang, 2019, Predictive and diagnostic biomarkers for gestational diabetes and its associated metabolic and cardiovascular diseases, Cardiovasc. Diabetol. sourceExperimental — accuracy not yet measured
The Conclusion identifies adiponectin, afamin and 1,5-anhydroglucitol as potential predictors of GDM. It also identifies several other candidates and does not rank these three as the most promising. (LLM, conf=0.83)
- Not checked — no full text of the sourcecites [35] Corcoran, 2018, First trimester serum biomarkers to predict gestational diabetes in a high-risk cohort: Striving for clinically useful thresholds, Eur. J. Obstet. Gynecol. Reprod. Biol. source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“GDM in a previous pregnancy increases the risk of reoccurrence by more than six times [17].”
§ Gestational Diabetes Mellitus—Recent Literature Review > 4. Results and Discussion > 4.2. GDM Risk Factors
What the sources say
- Partly supportedcites [17] Kim, 2007, Recurrence of Gestational Diabetes Mellitus A systematic review, Diabetes Care sourceExperimental — accuracy not yet measured
The introduction (p. 1) says women with a history of GDM have an increased risk of recurrent GDM, and Search for published data (p. 2) reports recurrence rates of 30–84% among women who became pregnant again. The paper does not establish that a previous GDM pregnancy increases recurrence risk by more than six times; the reported percentages are recurrence rates, not a sixfold comparison with women without prior GDM. (LLM, conf=0.85)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Screening of only risk groups may result in GDM not being diagnosed in as many as 35–47% of pregnant women, which is certain to affect obstetric results [25].”
§ Gestational Diabetes Mellitus—Recent Literature Review > 4. Results and Discussion > 4.3. Diagnosing GDM
What the sources say
- Partly supportedcites [25] Benhalima, 2013, Analysis of pregnancy outcomes using the new IADPSG recommendation compared with the Carpenter and Coustan criteria in an area with a low prevalence of gestational diabetes, Int. J. Endocrinol. sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) says a two-step glucose-test strategy may miss some GDM cases, and reports worse pregnancy outcomes among women identified only by the newer diagnostic criteria. It does not assess screening only risk groups or support the claimed 35–47% missed-diagnosis figure; the screening strategy it discusses is different. (LLM, conf=0.85)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“We observe GDM in both obese and lean women [37].”
§ Gestational Diabetes Mellitus—Recent Literature Review > 4. Results and Discussion > 4.4. Pathogenesis of Carbohydrate Metabolism Disorders in Pregnancy
What the sources say
- Supportedcites [37] Yong, 2020, Independent and combined effects of age, body mass index and gestational weight gain on the risk of gestational diabetes mellitus, Sci. Rep. source
Table 2 (Results, ‘Risk factors between non-GDM and GDM women’; page unavailable) reports 131 GDM cases among overweight/obese women and, by subtraction from the 255 total cases, 124 among women outside that group. The Results also compare GDM risk in overweight/obese women with underweight/normal-weight women. The paper uses combined BMI categories rather than reporting separate counts for obese and lean women, but supports the claim that GDM occurs across these weight groups. (LLM, conf=0.86)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
45 more claims · 22 with their cited sources checked
Create a free account to see all 96 claims and to verify the 13 references still open.
- It may state two separate claims as one. 41
- Probably not a substantial claim. 11
- The quote only partly states this claim. 1
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Gestational Diabetes Mellitus—Recent Literature Review > 1. Introduction
“GDM affects approximately 14.0% (95% confidence interval: 13.97–14.04%) of pregnancies worldwide”
§ Gestational Diabetes Mellitus—Recent Literature Review > 4. Results and Discussion > 4.1. Epidemiology
“more than approximately 20.4 million women (14.0% of pregnancies) presented with disorders of carbohydrate metabolism, of which approximately 80% was GDM”
Citations
Cites
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Marso, S. P., Daniels, G. H., Brown-Frandsen, K., Kristensen, P., Mann, J. F. E., Nauck, M. A., Nissen, S. E., Pocock, S., Poulter, N. R., Ravn, L. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603827 · Cited by 7,629
Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes
Crowther, C. A., Hiller, J. E., Moss, J. R., McPhee, A. J., Jeffries, W. S., & Robinson, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042973 · Cited by 3,159
Alogliptin after acute coronary syndrome in patients with type 2 diabetes
White, W. B., Cannon, C. P., Heller, S. R., Nissen, S. E., Bergenstal, R. M., Bakris, G. L., Perez, A. T., Fleck, P. R., Mehta, C. R., Kupfer, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1305889 · Cited by 2,502
Allotey, J., Fernandez, S., Bonet, M., Stallings, E., Yap, M., Kew, T., Zhou, D., Coomar, D., Sheikh, J., Lawson, H., et al. (2020) · BMJ · doi:10.1136/bmj.m3320 · Cited by 2,304
A Multicenter, Randomized Trial of Treatment for Mild Gestational Diabetes
Landon, M. B., Spong, C. Y., Thom, E., Carpenter, M. W., Ramin, S. M., Casey, B., Wapner, R. J., Varner, M. W., Rouse, D. J., Thorp, J. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902430 · Cited by 2,122 · cited 2×
“Patients who cannot achieve glycemic targets with a properly balanced diet and elimination of dietary errors should be treated pharmacologically [29].”
BackgroundThe Pathophysiology of Gestational Diabetes Mellitus
Plows, J. F., Stanley, J. L., Baker, P. N., Reynolds, C. M., & Vickers, M. H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113342 · Cited by 1,874 · cited 3×
“An increased secretion of insulin-antagonistic hormones (placental hormones, cortisol) during pregnancy results in an increased insulin resistance, which, at the end of the third trimester, reaches a value similar to full-blown type 2 diabetes [9,42].”
BackgroundMcIntyre, H. D., Catalano, P., Zhang, C., Desoye, G., Mathiesen, E. R., & Damm, P. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0098-8 · Cited by 1,850
Metformin versus insulin for the treatment of gestational diabetes
Rowan, J. A., Hague, W. M., Gao, W., Battin, M. R., & Moore, M. P. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707193 · Cited by 1,291
Wang, H., Li, N., Chivese, T., Werfalli, M., Sun, H., Yuen, L., Hoegfeldt, C. A., Elise Powe, C., Immanuel, J., Karuranga, S., et al. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.109050 · Cited by 1,260
Cellular Mechanisms for Insulin Resistance in Normal Pregnancy and Gestational Diabetes
Barbour, L. A., McCurdy, C. E., Hernandez, T. L., Kirwan, J. P., Catalano, P. M., & Friedman, J. E. (2007) · Diabetes Care · doi:10.2337/dc07-s202 · Cited by 811
Research works printed but not linked: 3
- Kumar, 2020, Autoimmunity in Gestational Diabetes A Decade after the HAPO Study, Front. Diabetes, 28, 234
- Chao, 2019, Dietary control plus nutrition guidance for blood glucose and pregnancy outcomes in women with gestational diabetes, Int. J. Clin. Exp. Med., 12, 2773
- Rasmussen, K.M., and Yaktine, A.L. (2009). Weight Gain During Pregnancy: Reexamining the Guidelines (2009), The National Academies Press.
Cited by
Reproductive risk factors across the female lifecourse and later metabolic health
Nichols, A. R., Chavarro, J., & Oken, E. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.01.002 · Cited by 63
Polystyrene microplastics disturb maternal glucose homeostasis and induce adverse pregnancy outcomes
Zhang, R., Feng, Y., Nie, P., Wang, W., Wu, H., Wan, X., Xu, H., & Fu, F. (2024) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2024.116492 · Cited by 46
Gao, Y., Hu, Y., & Xiang, L. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04322-0 · Cited by 37
Xie, W., Zhang, L., Cheng, J., Wang, Y., Kang, H., & Gao, Y. (2024) · BMC Public Health · doi:10.1186/s12889-024-18131-7 · Cited by 41
“…of both the mother and infant is adversely affected by GDM: pregnant women with GDM have a greater risk of obesity and hypertension in the short term, while the long-term risks for offspring born to mothers with GDM include an increased risk of developing type 2 diabetes mellitus (T2DM) [5, 6].”
BackgroundThyroid dysfunction during gestation and gestational diabetes mellitus: a complex relationship
Pinto, S., Croce, L., Lea, C., Cosson, E., & Rotondi, M. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02079-3 · Cited by 44
Metadata
- Authors
- Modzelewski, R., Stefanowicz-Rutkowska, M. M., Matuszewski, W., & Bandurska-Stankiewicz, E. M.
- Affiliations
- University of Warmia and Mazury in Olsztyn (PL)
- Wroclaw Medical University (PL)
- Corresponding author
- Stefanowicz-Rutkowska, Magdalena Maria
- ORCID
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2022-09-28
- Volume
- 11
- Issue
- 19
- Pages
- 5736
- ISSN
- 2077-0383 (ISSN-L)
- PMC
- PMC9572242
- OpenAlex
- W4297478345
- Cited by
- 223
- References
- 128
- Citations by year
- 2026: 65 · 2025: 74 · 2024: 62 · 2023: 22
- FWCI
- 7.94
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- gestational diabetes mellitus, hyperglycemia in pregnancy, risk factors, pathogenesis, SARS-CoV-2, diagnosis, treatment, insulin, metformin, glibenclamide, diet and exercise, type 2 diabetes risk, perinatal complications, economic burden
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Gestational Diabetes Mellitus—Recent Literature Review. https://app.cochat.ai/papers/10.3390/jcm11195736
- The paper
- Modzelewski, R., Stefanowicz-Rutkowska, M. M., Matuszewski, W., & Bandurska-Stankiewicz, E. M. (2022). Gestational Diabetes Mellitus—Recent Literature Review. Journal of Clinical Medicine. https://doi.org/10.3390/jcm11195736
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.